News & Updates
Filter by Specialty:
Tezepelumab cuts OCS use in OCS-dependent patients with severe asthma
Patients with severe asthma who were dependent on oral corticosteroid (OCS) were able to reduce their use of maintenance OCS after treatment with the monoclonal antibody tezepelumab, according to findings from the interim analysis of the phase IIIb WAYFINDER trial.
Tezepelumab cuts OCS use in OCS-dependent patients with severe asthma
15 Nov 2023
Shorter outshines longer DAPT for ACS patients following DES implantation
In patients treated with drug-eluting stents (DES) for acute coronary syndrome (ACS), stopping aspirin within a month of dual antiplatelet therapy (DAPT) and continuing with ticagrelor alone outdid a 12-month DAPT regimen with ticagrelor and aspirin, findings from the T-PASS trial have shown.
Shorter outshines longer DAPT for ACS patients following DES implantation
14 Nov 2023
Multimodal intervention reduces second-line antibiotic prescriptions for UTI
A multimodal intervention applied in general practice results in a significant decrease in antibiotic prescribing and an increase in guideline adherence among women with uncomplicated urinary tract infection (UTI), a study has shown.
